FUSIONSPROTEINE UND KOMBINATIONSIMPFSTOFFE

Patent europeic · EP3321287 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3321287
Numer da la dumonda
EP17201766
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
12-04-2012
Publitgà
16-05-2018
Concedì
26-02-2020
La protecziun finescha il pli tard
11-04-2032
Proxima taxa annuala scadenta
30-04-2026
Classas IPC
C07K 19/00 (2006.01)
A61K 39/145 (2006.01)
A61K 39/385 (2006.01)
A61P 31/16 (2006.01)
A61P 37/04 (2006.01)
C07K 14/285 (2006.01)
C12N 15/00 (2006.01)
C12P 21/02 (2006.01)
Prioritad
US 201161474779 P 13.04.2011
US 201161534012 P 13.09.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-05-2025

    Midada

    Published in Swissreg on 01.05.2025

  2. 01-05-2024

    Midada

    Published in Swissreg on 01.05.2024

  3. 01-05-2023

    Midada

    Published in Swissreg on 01.05.2023

  4. 27-02-2020

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in Swissreg on 27.02.2020

  5. 26-02-2020

    Concedì

    Published in Swissreg on 26.02.2020

Partidas

Possessur

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut, 89, 1330 Rixensart, BE

Represchentant

Isler & Pedrazzini AG

Postfach 1772, 8027 Zürich

Inventur

POOLMAN, Jan

1330 Rixensart, BE

BLAIS, Normand

Laval, Québec H7V 3S8, CA

LABBE, Steve

Laval, Québec H7V 3S8, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.